Despite regulatory progress in many countries, skepticism and a lack of robust randomized trials continue to limit the use of medical cannabis in rheumatology.

Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and ...

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...

Rheumatoid arthritis, or RA, is an autoimmune and inflammatory disease that primarily affects joints. The disorder is ...

According to study co-lead author Qizhi Qin, Ph.D., a postdoctoral fellow in the James Laboratory, the researchers also found ...